PerkinElmer (PKI) - FREE Research Report Okun Andrew who is VP & Chief Accounting Officer at PerkinElmer sold 6,805 shares at $36.86 on Sept. 10, 2013. Following this transaction, the VP & Chief Accounting Officer owned 10,517 shares meaning that the stake was reduced by 39.29% with the 6,805 share transaction. The shares most recently traded at $37.93, up $1.07, or 2.83% since the insider transaction. The average volume for PerkinElmer has been 951,400 shares per day over the past 30 days. PerkinElmer has a market cap of $4.2 billion and is part of the health care sector and health services industry. Shares are up 18.78% year to date as of the close of trading on Tuesday. PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates in two segments, Human Health and Environmental Health. The stock currently has a dividend yield of 0.75%. The company has a P/E ratio of 59.4. Currently there are 8 analysts that rate PerkinElmer a buy, no analysts rate it a sell, and 5 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on PKI - FREE TheStreet Quant Ratings rates PerkinElmer as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full PerkinElmer Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts